RJ
Robert L Dixon JR
Director

Robert L Dixon JR insider trades: Elevance Health (ELV) stock sales

Director, Elevance Health Last trade Jun 11, 2026 47 Form 4 filings
$61K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2018
5
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Robert reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 11, 2026ELV↓ Sell$61K
Jul 19, 2024ELV↓ Sell$155K
Sep 1, 2023BBW↓ Sell$215K
Jul 21, 2023ELV↓ Sell$148K
Sep 8, 2022OKTA↓ Sell$24K
Jun 14, 2022BBW↓ Sell$34K
Jun 6, 2022ANTM↓ Sell$209K
Sep 9, 2021OKTA↓ Sell$211K
Jun 16, 2021BBW↓ Sell$219K
May 21, 2021ANTM↓ Sell$232K
May 27, 2020ANTM↓ Sell$314K
Jul 26, 2019ANTM↓ Sell$153K
May 18, 2018ANTM↓ Sell$231K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ELV insiders

Open-market trades in the last 12 months

About Robert L Dixon JR's insider trades

Robert L Dixon JR is a director at Elevance Health (ELV). Since May 18, 2018, Robert has reported no open-market purchases and 13 sales worth $2.2M on SEC Form 4. In the last 12 months: 1 sale ($61K).

Their filings also include grants and awards (30 filings), option exercises (8 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ELV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.